-
... and crime rates for major felonies: A research note. Journal of Research in Crime and Delinquency...Journal of Clinical Pharmacy and Therapeutics 27 : 299-309. . Weisburd...
-
... of whom worked at Erl Wood, Lilly’s research facility in Sussex , United Kingdom . The ‘687 p... to healthy volunteers, and then to begin clinical trials with patients experiencing schizophrenia. [..., and chair of the pharmacy and therapeutics committee at the Hennepin County Medical Centre in...
-
... of whom worked at Erl Wood, Lilly’s research facility in Sussex , United Kingdom . The ‘687 p... to healthy volunteers, and then to begin clinical trials with patients experiencing schizophrenia. [..., and chair of the pharmacy and therapeutics committee at the Hennepin County Medical Centre in...
-
Codeine is commonly used by women to relieve the pain associated with childbirth and is widely believed to be safe for those who breastfeed. But what the fatal case in Toronto highlighted, said [Gideon Koren] in an interview, is that "what may be safe for many may be life threatening for a few.
I don't think women should panic," said Koren. "They should talk to their physicians about this for sure, I think that's the most immediate advice. Talk about other alternatives or whether you need such a high dose or what to do."
"It does point toward an area of potential concern," he said. The study shows that the fatality in Toronto wasn't necessarily a one-in-a-million type of case and that the potential problems with breastfeeding and pain killers may be more common than originally thought...
...The research, published Wednesday in the journal Clinical Pharmmacology and Therapeutics, and led by Dr. Gideon Koren at Toronto's Hospital...
-
... of whom worked at Erl Wood, Lilly’s research facility in Sussex , United Kingdom . The ‘687 p... to healthy volunteers, and then to begin clinical trials with patients experiencing schizophrenia. [..., and chair of the pharmacy and therapeutics committee at the Hennepin County Medical Centre in...
-
... of the Massachusetts General Hospital clinical study (the MGH Study) that constituted Lilly's evi... views about what depth or quality of research is required to prove the utility of a medicinal co...-Group Study (2007) 29(3) Clinical Therapeutics 450 at 458. [20] Novopharm argues that the Patent ...
-
... of the Massachusetts General Hospital clinical study (the MGH Study) that constituted Lilly's evi... views about what depth or quality of research is required to prove the utility of a medicinal co...-Group Study (2007) 29(3) Clinical Therapeutics 450 at 458. [20] Novopharm argues that the Patent ...
-
...Over the next decade, additional research by Marshall and Warren and others in the field pro...[97] The “Indications and Clinical Use” section of the monograph also begins with t... Alimentary Pharmacology and Therapeutics, and Gastroenterology & Hepatology, and is an edit...
-
One example is the hematopoietic stem cell of bone marrow, a "master" cell that generates all cellular components of our immune system. Embryonic and adult stem cells differ in their origins, and the number of different cell types that they can change into.
The pioneer work by two Canadian scientists, Ernest A. McCulloch and James E. Till in the 1960s, demonstrates the existence of adult stem cells in mouse bone marrow. Their finding started the era of stem cell research, and formed the basis of bone marrow transplant in clinical practices.
Adult stem cells are usually more limited in producing only functionally related cell types. However, it is important that we recognize, but not exclude, the quest in understanding the biology of this unusual cell type and the potential benefits of...
... . The excitement and promising therapeutics of stem cell research lie in these two functional ...
-
...He works as an anesthesiologist and clinical scientist in the field of clinical pharmacology. D... in the area of biomaterials, polymer therapeutics, and drug delivery (including controlled release t... is a consulting company that provides research and development services to the pharmaceutical sec...